NFKB1 and prediabetes syndrome: In the current pilot study, the expressions of ZBP1, DDX58, NFKB1 and CHUK were significantly higher in the T2DM group compared to either healthy control or pre-DM patients, which may give us new predictive markers for the development of T2DM in prediabetes patients.